Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
39.71
+0.85 (2.19%)
At close: Dec 15, 2025, 4:00 PM EST
39.71
0.00 (0.00%)
After-hours: Dec 15, 2025, 4:10 PM EST

Maze Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Maze Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $41, which forecasts a 3.25% increase in the stock price over the next year. The lowest target is $28 and the highest is $60.

Price Target: $41 (+3.25%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$28$41$37$60
Change-29.49%+3.25%-6.82%+51.10%

Analyst Ratings

The average analyst rating for Maze Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy223333
Buy333334
Hold000000
Sell000000
Strong Sell000000
Total556667

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Buy
Initiates
$55
BuyInitiates$55+38.50%Dec 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$50$60
Strong BuyMaintains$50$60+51.10%Dec 3, 2025
Wedbush
Wedbush
Buy
Maintains
$35$36
BuyMaintains$35$36-9.34%Nov 7, 2025
JP Morgan
JP Morgan
Buy
Maintains
$27$37
BuyMaintains$27$37-6.82%Sep 29, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$50
Strong BuyReiterates$50+25.91%Sep 18, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 167.50M
Revenue Next Year
1.53M
EPS This Year
-3.27
from 1.25
EPS Next Year
-3.15
from -3.27
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028
Revenue
--167.50M-1.53M3.66M46.95M
Revenue Growth
-----139.02%1,183.81%
EPS
-57.18-43.891.25-3.27-3.15-3.33-2.62
EPS Growth
-------
Forward PE
-------
No. Analysts
---101094
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
Highn/a12.6M
Avgn/a1.5M
Lown/an/a

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-3.21-2.71
Avg-3.27-3.15
Low-3.38-3.96

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.